The transcription factor Zfp281 sustains CD4 + T lymphocyte activation through directly repressing Ctla-4 transcription

Jing Guo,Zhonghui Xue,Ruoyu Ma,Weiwei Yi,Zhaoyuan Hui,Yixin Guo,Yuxi Yao,Wenqiang Cao,Jianli Wang,Zhenyu Ju,Linrong Lu,Lie Wang
DOI: https://doi.org/10.1038/s41423-019-0289-y
2019-01-01
Abstract:The expression of coinhibitory receptors, such as CTLA-4, on effector T cells is a key mechanism for the negative regulation of T-cell activation. However, the transcriptional regulation of CTLA-4 is not well understood. Zfp281, a C2H2 zinc finger protein, is a negative regulator of pluripotency maintenance of embryonic stem cells. Nevertheless, the function of Zfp281 in differentiated cells has not been studied. We generated Zfp281 conditional knockout mice in which the function of the Zfp281 gene was conditionally disrupted by the Cd4 Cre transgene to study its impact on T cell function. Zfp281 had no effect on T-cell development, but CD4 + T cell activation and cytokine production were impaired due to diminished T-cell receptor signaling. Furthermore, Zfp281 deficiency inhibited in vivo T cell responses to Listeria monocytogenes infection. Using genome-wide expression profiling assays, we determined that Zfp281 repressed Ctla-4 expression by directly binding to GC-rich sites in its promoter, which inhibited the negative feedback of T cell activation. In line with this result, CTLA-4 blockade and shRNA knockdown partly rescued the reduced cytokine production caused by Zfp281 deficiency. These findings indicate that Zfp281 sustains CD4 + T lymphocyte activation by directly repressing Ctla-4 transcription.
What problem does this paper attempt to address?